(Q53994091)

23 May 2018

title

Can an optimization/scoring procedure in ligand-protein docking be employed to probe drug-resistant mutations in proteins? (English)

1 reference

23 May 2018

author name string

Chen YZ

series ordinal

1

1 reference

23 May 2018

Gu XL

series ordinal

2

1 reference

23 May 2018

Cao ZW

series ordinal

3

1 reference

23 May 2018

publication date

1 January 2001

1 reference

23 May 2018

Journal of Molecular Graphics & Modelling

published in

1 reference

23 May 2018

volume

19

1 reference

23 May 2018

issue

6

1 reference

23 May 2018

page(s)

560-570

1 reference

23 May 2018

Structure-based strategies for drug design and discovery

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1093-3263%2801%2900091-2

7 January 2021

A fast flexible docking method using an incremental construction algorithm.

1 reference

https://api.crossref.org/works/10.1016%2FS1093-3263%2801%2900091-2

7 January 2021

Development and validation of a genetic algorithm for flexible docking

1 reference

https://api.crossref.org/works/10.1016%2FS1093-3263%2801%2900091-2

7 January 2021

Consensus scoring: A method for obtaining improved hit rates from docking databases of three-dimensional structures into proteins.

1 reference

https://api.crossref.org/works/10.1016%2FS1093-3263%2801%2900091-2

7 January 2021

A general and fast scoring function for protein-ligand interactions: a simplified potential approach.

1 reference

https://api.crossref.org/works/10.1016%2FS1093-3263%2801%2900091-2

7 January 2021

Binding of an antiviral agent to a sensitive and a resistant human rhinovirus. Computer simulation studies with sampling of amino acid side-chain conformations. II. Calculation of free-energy differences by thermodynamic integration.

1 reference

https://api.crossref.org/works/10.1016%2FS1093-3263%2801%2900091-2

7 January 2021

Molecular mechanisms of drug resistance in Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1093-3263%2801%2900091-2

7 January 2021

Structural mechanisms of HIV drug resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1093-3263%2801%2900091-2

7 January 2021

Molecular basis of HIV-1 protease drug resistance: structural analysis of mutant proteases complexed with cyclic urea inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS1093-3263%2801%2900091-2

7 January 2021

Modification of the NADH of the isoniazid target (InhA) from Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1093-3263%2801%2900091-2

7 January 2021

Resistance to HIV protease inhibitors: a comparison of enzyme inhibition and antiviral potency

1 reference

https://api.crossref.org/works/10.1016%2FS1093-3263%2801%2900091-2

7 January 2021

Solvation effects are responsible for the reduced inhibitor affinity of some HIV-1 PR mutants

1 reference

https://api.crossref.org/works/10.1016%2FS1093-3263%2801%2900091-2

7 January 2021

A new method for predicting binding affinity in computer-aided drug design

1 reference

https://api.crossref.org/works/10.1016%2FS1093-3263%2801%2900091-2

7 January 2021

Binding affinities for sulfonamide inhibitors with human thrombin using Monte Carlo simulations with a linear response method

1 reference

https://api.crossref.org/works/10.1016%2FS1093-3263%2801%2900091-2

7 January 2021

Analysis of a series of phenylalanine 57 mutants of the adipocyte lipid-binding protein

1 reference

https://api.crossref.org/works/10.1016%2FS1093-3263%2801%2900091-2

7 January 2021

Resistance and cross-resistance with saquinavir and other HIV protease inhibitors: theory and practice

1 reference

https://api.crossref.org/works/10.1016%2FS1093-3263%2801%2900091-2

7 January 2021

HIV resistance to reverse transcriptase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS1093-3263%2801%2900091-2

7 January 2021

Novel binding mode of highly potent HIV-proteinase inhibitors incorporating the (R)-hydroxyethylamine isostere

1 reference

https://api.crossref.org/works/10.1016%2FS1093-3263%2801%2900091-2

7 January 2021

An orally bioavailable HIV-1 protease inhibitor containing an imidazole-derived peptide bond replacement: crystallographic and pharmacokinetic analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1093-3263%2801%2900091-2

7 January 2021

Crystal structures of complexes of a peptidic inhibitor with wild-type and two mutant HIV-1 proteases

1 reference

https://api.crossref.org/works/10.1016%2FS1093-3263%2801%2900091-2

7 January 2021

High resolution structures of HIV-1 RT from four RT-inhibitor complexes

1 reference

https://api.crossref.org/works/10.1016%2FS1093-3263%2801%2900091-2

7 January 2021

Crystal structures of 8-Cl and 9-Cl TIBO complexed with wild-type HIV-1 RT and 8-Cl TIBO complexed with the Tyr181Cys HIV-1 RT drug-resistant mutant

1 reference

https://api.crossref.org/works/10.1016%2FS1093-3263%2801%2900091-2

7 January 2021

Internal motions of antibody molecules

1 reference

https://api.crossref.org/works/10.1016%2FS1093-3263%2801%2900091-2

7 January 2021

Premelting thermal fluctuational interbase hydrogen-bond disrupted states of a B-DNA guanine-cytosine base pair: significance for amino and imino proton exchange

1 reference

https://api.crossref.org/works/10.1016%2FS1093-3263%2801%2900091-2

7 January 2021

The role of a minor groove spine of hydration in stabilizing poly(dA). poly(dT) against fuctuational interbase H-bond disruption in the premelting temperature regime

1 reference

https://api.crossref.org/works/10.1016%2FS1093-3263%2801%2900091-2

7 January 2021

Solvation energy in protein folding and binding

1 reference

https://api.crossref.org/works/10.1016%2FS1093-3263%2801%2900091-2

7 January 2021

Atomic solvation parameters applied to molecular dynamics of proteins in solution

1 reference

https://api.crossref.org/works/10.1016%2FS1093-3263%2801%2900091-2

7 January 2021

Cation-pi interactions in chemistry and biology: a new view of benzene, Phe, Tyr, and Trp

1 reference

https://api.crossref.org/works/10.1016%2FS1093-3263%2801%2900091-2

7 January 2021

Mutational anatomy of an HIV-1 protease variant conferring cross-resistance to protease inhibitors in clinical trials. Compensatory modulations of binding and activity

1 reference

https://api.crossref.org/works/10.1016%2FS1093-3263%2801%2900091-2

7 January 2021

pi-Stacking interactions. Alive and well in proteins

1 reference

https://api.crossref.org/works/10.1016%2FS1093-3263%2801%2900091-2

7 January 2021

Structure-based thermodynamic analysis of HIV-1 protease inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS1093-3263%2801%2900091-2

7 January 2021

Prediction of Binding Affinities for TIBO Inhibitors of HIV-1 Reverse Transcriptase Using Monte Carlo Simulations in a Linear Response Method

1 reference

https://api.crossref.org/works/10.1016%2FS1093-3263%2801%2900091-2

7 January 2021

Dominant forces in protein folding

1 reference

https://api.crossref.org/works/10.1016%2FS1093-3263%2801%2900091-2

7 January 2021

Effect of point mutations on the kinetics and the inhibition of human immunodeficiency virus type 1 protease: relationship to drug resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1093-3263%2801%2900091-2

7 January 2021

10.1016/S1093-3263(01)00091-2

Identifiers

DOI

1 reference

23 May 2018

1 reference

23 May 2018